In a large population of people with diabetes, the use of GLP-1 receptor agonists was not linked to an increased risk for ...

BMI falls short as a way to measure obesity. Doctors need to also determine whether body fat harms a person's health.

A study has found no evidence that glucagon-like peptide 1 receptor agonist (GLP1-RA) use is associated with an increased ...

The following is a summary of “Association between incretin-based drugs and risk of cholangiocarcinoma among patients with ...

While weight loss is a common new year's resolution for workers in the U.S., 2025 may mark the year that building weight loss ...

Cancer researchers found that patients on GLP-1s had significant risk reductions for 10 of 13 obesity-associated cancers.

Patients with obesity and comorbid cardiovascular disease were more likely to ration prescription drugs than those without obesity.

A dozen GLP-1 receptor agonists and coagonists demonstrated effectiveness for weight loss in adults with obesity and without ...

Scientists have found a way to help the body make more of an Ozempic-like fullness hormone to cut cravings and improve health.

Semaglutide combined with automated insulin delivery enhances glucose control in type 1 diabetes, lowering insulin ...

The following is a summary of “Effects of Novel Antidiabetic Agents on Contrast-Associated Acute Kidney Injury in Diabetic Patients Undergoing Percutaneous Coronary Intervention,” published in the ...

Australia is home to some truly unique and unexpected creatures, but few are quite as strange and fascinating as the platypus ...